See also: New Drug Approvals for 2003
Ebglyss (lebrikizumab-lbkz) is a targeted IL-13 inhibitor used for the...
Ocrevus Zunovo (ocrelizumab & hyaluronidase-ocsq) is a CD20-directed cytolytic...
Pavblu (aflibercept-ayyh) is a vascular endothelial growth factor (VEGF)...
More drug approvals